Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule,Zephir Inhaler Device
Completed · Phase 1
Conditions studied: COPD
In brief
An Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule, Inhaler Device. Zephir inhaler robustness will be assessed by in vitro testing of the Zephir inhaler after 12 weeks of patient use
Key facts
- Study ID
- NCT06254664
- Run by
- Xiromed LLC
- People needed
- 116
- Starts
- 2022-10-03
- Expected to finish
- 2023-10-27
- Last updated by the study team
- 2024-02-12
Who can join
Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Vanguard Clinical Research, LLC — Fort Myers, Florida, United States
- Clinical Research Solutions - Orlando — Kissimmee, Florida, United States
- Clintex Research Group — Miami, Florida, United States
- My Preferred Research LLC — Miami, Florida, United States
- Research Institute of South Florida, Inc. — Miami, Florida, United States
- Vista Health Research — Miami, Florida, United States
- Greater Providence Clinical Research, LLC — Cranston, Rhode Island, United States
- Inquest Clinical Research, LL — Cypress, Texas, United States
- Cliantha Research — Ahmedabad, Gujarat, India
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.